| Application no. and date | 09793543.1 (espacenet) (Federated) (European Patent Register), 20091218 | | Patent/reg. no. and date | DK/EP 2379600, 20140122 | | Publication date | 20111026 | | Priority no. and date | EP 08172520, 20081222 | | EP pub. no. and date |
EP 2379600 20111026 | | Effective date | | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | | Applicant ref. no. | P74721DK01 | | Inventor | HILDEN, Ida, Grøndals Parkvej 58, 2720 Vanløse, DK,
CLAUSEN, Jes Thorn, Davrekildevej 10, 4270 Høng, DK,
KROGH, Berit Olsen, Vamdrupvej 57, 2610 Rødovre, DK,
OLSEN, Ole Hvilsted, Bækkeskovvej 38
1., 2700 Brønshøj, DK,
BREINHOLT, Jens, Aftenbakken 18, 2870 Dyssegård, DK,
LAURITZEN, Brian, Kagsåbrinken 23, 2730 Herlev, DK,
SÿRENSEN, Brit Binow, Marianelundsvej 1, 3460 Birkerød, DK | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 7/04 (2006.01) , C07K 16/38 (2006.01) | | Title | ANTISTOFFER MOD TISSUE FACTOR PATHWAY INHIBITOR | | Int. application no. | EP2009067598 | | Int. publication no. | WO2010072691 | | Related patent (certificate) | CA 2025 00012 | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
